A short overview of dual targeting HDAC inhibitors

被引：0

作者：

Liu, Wen-Bo ^{[1
]}

Song, Jian ^{[1
]}

Zhang, Sai-Yang ^{[1
,2
]}

机构：

[1] Zhengzhou Univ, Sch Basic Med Sci, Zhengzhou 450001, Peoples R China

[2] State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou, Peoples R China

来源：

FUTURE MEDICINAL CHEMISTRY | 2025年 / 17卷 / 01期

基金：

中国国家自然科学基金;

关键词：

HDACs; HDAC inhibitors; dual targeting; drug resistance; HISTONE DEACETYLASE INHIBITORS;

D O I：

10.1080/17568919.2024.2437975

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：5 / 7

页数：3

共 21 条

[11] Designed multiple ligands. An emerging drug discovery paradigm [J].

Morphy, R ;

Rankovic, Z .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (21) :6523-6543

[12] Discovery of Thieno[2,3-d]pyrimidine-Based Hydroxamic Acid Derivatives as Bromodomain-Containing Protein 4/Histone Deacetylase Dual Inhibitors Induce Autophagic Cell Death in Colorectal Carcinoma Cells [J].

Pan, Zhaoping ;

Li, Xiang ;

Wang, Yujia ;

Jiang, Qinglin ;

Jiang, Li ;

Zhang, Min ;

Zhang, Nan ;

Wu, Fengbo ;

Liu, Bo ;

He, Gu .

JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (07) :3678-3700

[13] Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers [J].

Sanaei, Masumeh ;

Kavoosi, Fraidoon .

ADVANCED BIOMEDICAL RESEARCH, 2019, 8 (01) :63

[14] Advances in targeting histone deacetylase for treatment of solid tumors [J].

Shi, Mu-Qi ;

Xu, Ying ;

Fu, Xin ;

Pan, De-Si ;

Lu, Xian-Ping ;

Xiao, Yi ;

Jiang, Yi-Zhou .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)

[15] Development of Alkylated Hydrazides as Highly Potent and Selective Class I Histone Deacetylase Inhibitors with T cell Modulatory Properties [J].

Sun, Ping ;

Wang, Jing ;

Khan, Khadija S. ;

Yang, Weiqin ;

Ng, Billy Wai-Lung ;

Ilment, Nikita ;

Zessin, Matthes ;

Buelbuel, Emre F. ;

Robaa, Dina ;

Erdmann, Frank ;

Schmidt, Matthias ;

Romier, Christophe ;

Schutkowski, Mike ;

Cheng, Alfred Sze-Lok ;

Sippl, Wolfgang .

JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (24) :16313-16337

[16] Targeting HDAC/OAZ1 axis with a novel inhibitor effectively reverses cisplatin resistance in non-small cell lung cancer [J].

Sun, Yuhong ;

Bao, Xuefei ;

Ren, Yong ;

Jia, Lina ;

Zou, Shenglan ;

Han, Jian ;

Zhao, Mengyue ;

Han, Mei ;

Li, Hong ;

Hua, Qixiang ;

Fang, Yi ;

Yang, Jingyu ;

Wu, Chunfu ;

Chen, Guoliang ;

Wang, Lihui .

CELL DEATH & DISEASE, 2019, 10 (6)

[17] Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer [J].

Wang, Wenjing ;

Zhao, Mengyue ;

Cui, Lijuan ;

Ren, Yong ;

Zhang, Jingyuan ;

Chen, Junli ;

Jia, Lina ;

Zhang, Jiayu ;

Yang, Jingyu ;

Chen, Guoliang ;

Ashby, Charles R., Jr. ;

Wu, Chunfu ;

Chen, Zhe-Sheng ;

Wang, Lihui .

MOLECULAR CANCER, 2020, 19 (01)

[18] Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2 [J].

Wu, Chung-Pu ;

Hsiao, Sung-Han ;

Wu, Yu-Shan .

DRUG RESISTANCE UPDATES, 2023, 71

[19] Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer [J].

Zeng, Hanlin ;

Qu, Jia ;

Jin, Nan ;

Xu, Jun ;

Lin, Chenchu ;

Chen, Yi ;

Yang, Xinying ;

He, Xiang ;

Tang, Shuai ;

Lan, Xiaojing ;

Yang, Xiaotong ;

Chen, Ziqi ;

Huang, Min ;

Ding, Jian ;

Geng, Meiyu .

CANCER CELL, 2016, 30 (03) :459-473

[20] A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapy [J].

Zhang, Wei-Xin ;

Huang, Jiao ;

Tian, Xin-Yi ;

Liu, Yun-He ;

Jia, Mei-Qi ;

Wang, Wang ;

Jin, Cheng-Yun ;

Song, Jian ;

Zhang, Sai-Yang .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 259

← 1 2 3 →